Market Cap
$13.33B
$306.09M
Country
United States
United States
Employees
10590.0
796.0
Industry
🇺🇸 United States
🇺🇸 United States
Outstanding Shares
N/A
N/A
Comparison Verdict
About Illumina and Pacific Biosciences
Illumina (ILMN) and Pacific Biosciences (PACB) are both prominent companies in their respective sectors. This comparison helps investors understand the key differences between these two stocks.
Key Takeaways
- Market Cap: Illumina ($13.33B) vs Pacific Biosciences ($306.09M)
- Valuation: Illumina has a P/E ratio of $-8.50 vs $-0.93 for Pacific Biosciences
- Dividend Yield: Illumina offers 0.00% vs 0.00% from Pacific Biosciences
- Assets: Illumina has $6.30B in total assets compared to $1.26B for Pacific Biosciences
- 1-Year Performance: Illumina gained 0.84% vs gain of 0.01% for Pacific Biosciences